Skip to main content
. Author manuscript; available in PMC: 2015 Apr 1.
Published in final edited form as: Hum Pathol. 2013 Dec 18;45(4):834–843. doi: 10.1016/j.humpath.2013.12.002

Figure 3.

Figure 3

AKR1B10 expression in benign mass-forming liver lesions. Faint cytoplasmic staining of AKR1B10 can be observed in the proliferating cells adjacent to the central scar in focal nodular hyperplasia (A, 100X; B, 400X; C, 600X). Negligible AKR1B10 expression was identified in hepatic adenomas (D, 200X; E, 600X).